Alpha Teknova, Inc. (TKNO)
USD 4.33
(-7.48%)
USD 4.33
(-7.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.59 Million USD | -5.33% |
| 2022 | 12.24 Million USD | 127.05% |
| 2021 | 5.39 Million USD | 50.59% |
| 2020 | 3.58 Million USD | 39.59% |
| 2019 | 2.56 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 10.98 Million USD | -1.96% |
| 2024 Q1 | 11.2 Million USD | -3.34% |
| 2023 Q1 | 12.15 Million USD | -0.78% |
| 2023 Q3 | 11.46 Million USD | -4.58% |
| 2023 FY | 11.59 Million USD | -5.33% |
| 2023 Q2 | 12.01 Million USD | -1.09% |
| 2023 Q4 | 11.59 Million USD | 1.1% |
| 2022 Q3 | 10.32 Million USD | 30.52% |
| 2022 FY | 12.24 Million USD | 127.05% |
| 2022 Q4 | 12.24 Million USD | 18.64% |
| 2022 Q2 | 7.9 Million USD | 23.08% |
| 2022 Q1 | 6.42 Million USD | 19.13% |
| 2021 FY | 5.39 Million USD | 50.59% |
| 2021 Q3 | 4.4 Million USD | 13.48% |
| 2021 Q2 | 3.88 Million USD | 0.03% |
| 2021 Q1 | 3.87 Million USD | 8.29% |
| 2021 Q4 | 5.39 Million USD | 22.51% |
| 2020 Q4 | 3.58 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 3.58 Million USD | 39.59% |
| 2019 FY | 2.56 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | -142.094% |
| Safety Shot Inc | 1.86 Million USD | -520.117% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 92.377% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 89.573% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -71.281% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 64.141% |
| Dynavax Technologies Corporation | 53.29 Million USD | 78.244% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 82.332% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 0.455% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 88.89% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -102.171% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -102.171% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1331.788% |
| Journey Medical Corporation | 10.2 Million USD | -13.6% |
| Procaps Group, S.A. | 96.83 Million USD | 88.027% |
| Theratechnologies Inc. | 6.06 Million USD | -91.131% |
| Harrow Health, Inc. | 10.86 Million USD | -6.69% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -326.407% |
| Biofrontera Inc. | 10.9 Million USD | -6.289% |
| DURECT Corporation | 2.21 Million USD | -422.488% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 85.022% |
| Cronos Group Inc. | 30.33 Million USD | 61.785% |
| OptiNose, Inc. | 8.05 Million USD | -43.989% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1159399900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -103.438% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 58.964% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -333.079% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -151.532% |
| Radius Health, Inc. | 278.64 Million USD | 95.839% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -246.787% |
| ProPhase Labs, Inc. | 3.84 Million USD | -201.848% |
| Phibro Animal Health Corporation | 265.91 Million USD | 95.64% |
| Procaps Group S.A. | 96.83 Million USD | 88.027% |
| Alvotech | 74.43 Million USD | 84.424% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.666% |
| Rockwell Medical, Inc. | 5.87 Million USD | -97.479% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 8.224% |
| SIGA Technologies, Inc. | 64.21 Million USD | 81.946% |
| Tilray Brands, Inc. | 252.08 Million USD | 95.401% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 71.0% |
| Shineco, Inc. | 1.58 Million USD | -629.859% |
| PetIQ, Inc. | 159.3 Million USD | 92.722% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 7688.789% |
| Incannex Healthcare Limited | -10.01 Million USD | 215.766% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 69.728% |
| Alimera Sciences, Inc. | 1.87 Million USD | -517.03% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 69.235% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -619.949% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -158.621% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4458.25% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -11.696% |
| Hempacco Co., Inc. | 2.54 Million USD | -355.985% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 84.424% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 75.742% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 81.893% |
| Currenc Group, Inc. | 732.91 Thousand USD | -1481.911% |
| Kamada Ltd. | 87.74 Million USD | 86.787% |
| Indivior PLC | 141.79 Million USD | 91.824% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -2306.193% |
| Flora Growth Corp. | 8.5 Million USD | -36.272% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4458.25% |
| Evolus, Inc. | 10.99 Million USD | -5.419% |
| HUTCHMED (China) Limited | 50.25 Million USD | 76.931% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 89.045% |
| Akanda Corp. | 1.28 Million USD | -800.929% |